Dermaliq is a series a startup based in United States. 2 investors tracked. Status: zombie.
Dermaliq is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Dermaliq is a clinical-stage dermatology company developing novel topical therapies for common skin diseases using its proprietary water-free drug delivery platform, hyliQ.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.